CA
HUMA icon

Cliff Asness’s Humacyte HUMA Stock Holding History

Cliff Asness’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Buy
2,597,134
+672,443
+35% +$623K ﹤0.01% 2611
2026
Q1 		$1.17M Buy
1,924,691
+1,890,867
+5,590% +$1.97M ﹤0.01% 2675
2025
Q4 		$32.5K Sell
33,824
-224,242
-87% -$318K ﹤0.01% 3531
2025
Q3 		$449K Sell
258,066
-376,609
-59% -$738K ﹤0.01% 2869
2025
Q2 		$1.33M Buy
634,675
+620,118
+4,260% +$1.19M ﹤0.01% 2029
2025
Q1 		$24.8K Sell
14,557
-37,545
-72% -$141K ﹤0.01% 3119
2024
Q4 		$263K Sell
52,102
-14,921
-22% -$73.8K ﹤0.01% 2562
2024
Q3 		$365K Sell
67,023
-189,319
-74% -$1.25M ﹤0.01% 2304
2024
Q2 		$1.23M Buy
256,342
+233,422
+1,018% +$1.21M ﹤0.01% 1661
2024
Q1 		$71.3K Sell
22,920
-20,417
-47% -$68.7K ﹤0.01% 2363
2023
Q4 		$123K Buy
+43,337
New +$111K ﹤0.01% 2268
2022
Q3 		– Sell
-18,366
Closed -$59K – 2255
2022
Q2 		$59K Sell
18,366
-1,913
-9% -$10.6K ﹤0.01% 2124
2022
Q1 		$143K Buy
+20,279
New +$118K ﹤0.01% 2107

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Cliff Asness's HUMA Position: Q2 2026 in Review

Cliff Asness increased its Humacyte (HUMA) stake by 35% in Q2 2026, buying an estimated $623K and bringing the position to 2,597,134 shares worth $2.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2611.

Cliff Asness first reported a position in HUMA in Q1 2022 and has held it in 13 quarters since. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Cliff Asness held 2,597,134 shares of Humacyte worth $2.03M as of Q2 2026.
  • Cliff Asness bought 672,443 Humacyte shares in Q2 2026, an estimated $623K.
  • Humacyte made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2611 holding.
  • Cliff Asness first reported a position in Humacyte in Q1 2022 and has held it in 13 quarters since.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.